xtandi
astellas pharma europe b.v. - enzalutamide - prosztatikus daganatok - endokrin terápia - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
xospata
astellas pharma europe b.v. - gilteritinib-fumarát - leukémia, mieloid, akut - daganatellenes szerek - xospata az monoterápiában kezelésére felnőtt betegek esetében, akik visszaesett, vagy tűzálló akut myeloid leukémia (aml) egy flt3 mutáció.
padcev
astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - daganatellenes szerek - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.
forcid solutab 250 mg/62,5 mg diszpergálódó tabletta
astellas pharma kft. - egyesülnek -
forcid solutab 500 mg/125 mg diszpergálódó tabletta
astellas pharma kft. - egyesülnek -
forcid solutab 875 mg/125 mg diszpergálódó tabletta
astellas pharma kft. - egyesülnek -
duomox 1000 mg diszpergálódó tabletta
astellas pharma kft. - amoxicillin -
duomox 250 mg diszpergálódó tabletta
astellas pharma kft. - amoxicillin -
duomox 375 mg diszpergálódó tabletta
astellas pharma kft. - amoxicillin -
duomox 500 mg diszpergálódó tabletta
astellas pharma kft. - amoxicillin -